Take Control of Your Health Today Dont let cravings, hormonal imbalances, or stalled progress hold you back
Up to 64 higher bioavailability than pill form
Dosing more frequently than weekly : Semaglutide has a half-life of approximately one week, designed for once-weekly administration
Several important safety considerations from UK SmPCs include: Pancreatitis risk : Seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Diabetic retinopathy complications : Particularly with semaglutide in those with pre-existing retinopathy Dehydration and acute kidney injury : Possible with severe gastrointestinal side effects Hypoglycaemia : Increased risk when used with insulin or sulfonylureas (dose adjustment of these medications may be needed) Pregnancy/breastfeeding : Weight management GLP-1 agonists (Wegovy, Saxenda) are contraindicated in pregnancy and should be avoided during breastfeeding [5] [2] Regarding mental health specifically, regulatory agencies have scrutinised GLP-1 medications for potential psychiatric adverse effects

Safety and Efficacy of Micro-Dosing GLP-1 Medications Clinical Evidence Numerous studies have demonstrated the safety and efficacy of GLP-1 medications in supporting weight loss and wellness treatments
This formula is available in a capsule format with liposomal delivery, providing a 2-month supply